Infinia Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.18 M
as on 16-11-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
as on 16-11-2024
- Revenue 363.43%
(FY 2023)
- Profit 75.92%
(FY 2023)
- Ebitda 172.69%
(FY 2023)
- Net Worth -24.93%
(FY 2023)
- Total Assets 0.41%
(FY 2023)
About Infinia Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹2.50 Cr.
Sanket Chede, Prerana Patil, Petal Gangurde, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24299PN2020PTC196732
- Company No.
196732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Infinia Sciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehank Chede  | Director | 10-Dec-2020 | Current |
| Sanket Chede | Director | 10-Dec-2020 | Current |
| Prerana Patil | Additional Director | 01-Mar-2022 | Current |
| Petal Gangurde | Director | 10-Dec-2020 | Current |
| Surekha Chede | Director | 10-Dec-2020 | Current |
Financial Performance of Infinia Sciences.
Infinia Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 363.43% increase. The company also saw a substantial improvement in profitability, with a 75.92% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infinia Sciences?
Unlock access to Infinia Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Orbis Industrries Private LimitedActive 8 years 11 monthsSanket Chede, Prerana Patil and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Nov 2022 | ₹1.00 Cr | Open |
Others Creation Date: 11 May 2022 | ₹1.50 Cr | Open |
How Many Employees Work at Infinia Sciences?
Infinia Sciences has a workforce of 20 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infinia Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infinia Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
